Skip to main content
PatientsReferrer
 
Request Appointment
Image
https://www.qscan.com.au/wp-content/uploads/2021/05/Gus.jpg

Dr Gus
McKenzie

MBBS, FRANZCR
Specialties and interests
  • Body/abdominal imaging
  • Musculoskeletal imaging
About

Contrary to popular belief about radiologists, Gus enjoys meeting patients and referrers, and believes in a patient-centric approach to medicine, including radiology. He is also not above the use of dad jokes and has an unhealthy reliance on memes. 

Gus is a radiologist at Qscan Radiology Clinics. He completed his Bachelor of Medicine and Bachelor of Surgery at Griffith Medical School in 2010 and his specialist training with the Royal Australian and New Zealand College of Radiologists in 2018. 

Gus obtained a Bachelor of Biomedical Science in 2005, achieved first-class honours in Exercise Physiology, and was awarded a Physiological Society's Research grant in 2006.

Fellowships
  • Body/Abdominal Imaging and Musculoskeletal Imaging, Qscan Radiology Clinics, 2019
Other positions
  • National Doctor Body Lead
  • Body MRI multidisciplinary team meetings and surgical, gastrointestinal, and urology meetings
  • Teaching registrars and body fellows

News & Articles

 

Rare and Uncommon Cancer PET-CT Medicare Rebate

As of 1 November 2022, Medicare rebates are available for patients suffering from rare and uncommon cancers.

Radiofrequency Ablation (RFA) for managing chronic pain

Radiofrequency ablation (RFA) is an interventional procedure performed by a high trained Radiologist under imaging gu

PSMA PET-CT Medicare Rebate

As of 1 July 2022, Medicare rebates are available for patients suffering from prostate cancer.

Rare and Uncommon Cancer PET-CT Medicare Rebate

As of 1 November 2022, Medicare rebates are available for patients suffering from rare and uncommon cancers.

Radiofrequency Ablation (RFA) for managing chronic pain

Radiofrequency ablation (RFA) is an interventional procedure performed by a high trained Radiologist under imaging gu

PSMA PET-CT Medicare Rebate

As of 1 July 2022, Medicare rebates are available for patients suffering from prostate cancer.